Listed companies

Joseph Archer analyses the latest performance of the London market for the AIM Advisers Rankings Guide.

Emerging markets are crucial for UK-listed companies due to their rapid growth and expanding consumer bases. They offer diversification and opportunities for revenue growth, enhancing competitiveness and long-term shareholder value.

Correct reporting of impairments is undoubtedly difficult. We look at some of the reasons for this and summarise findings from the FRC’s recent review. 

Non-Executive Directors (NEDs) are valuable and powerful individuals in a listed company. They provide an impartial opinion and constructive challenge to the executive directors.

This in-depth guide explores how to appropriately account for intangible assets under IFRS, including its scope and measurement, impacts and information your auditors will need from you.

Read our Market Analysis – Q3 2024

Read our analysis of the UK’s listed markets for H1 2024, as we explore current market trends and what we expect from the future market’s position as we continue into H2 2024.

European Green Transition plc were one of few companies to float on AIM this year. Aiden Lavelle, CEO and Jack Kelly, CFO explain the reasons for their bold decision and why AIM hits the sweet spot for them.

Which IFRS 9 impairment considerations apply to related company loans? How do you apply expected credit losses? And how should you present related company loans in your financial reports?

Endorsement of the new ISSB standards is due early next year. We provide insight into the proposed requirements.

Accounting for your long-term contracts under IFRS 15 – Revenue from Contracts with Customers (“IFRS 15”) can be complex. We explore why you should keep an eye on loss making contracts and what your auditors need you to prepare.